Sentrant™ SENSH1628W (UDI 00643169150324)Recalls & reported problems
Medtronic, Inc. · SHEATH SENSH1628W SENTRANT HYDRO · Class 2
All models of Sentrant (21)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 2
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169150324), received between Apr 13, 2017 and Feb 5, 2018 — classified as 2 deaths, 1 malfunction.
The most frequently reported specific device problem is “Component Missing” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Component Missing1
- Difficult to Insert1
- Packaging Problem1
Patient problems
- Death2
- Myocardial Infarction1
- No Patient Involvement1
- Perforation of Vessels1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 5, 2018Component Missing; Packaging Problem; Component Missing; Packaging Problem
A SENTRANT WAS BEING PREPARED TO BE USED FOR A PATIENT IN AN EMERGENCY PROCEDURE. IT WAS REPORTED THAT A DILATOR WAS NOT PACKED IN THE PACKAGE. THE PROCEDURE WAS COMPLETED WITH THE USE OF ANOTHER PRODUCT. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: No Patient Involvement
MAUDE report 7241053 ↗DeathSep 28, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 5.4 CM ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THE MAIN BODY WAS PLACED ON THE RIGHT SIDE. A 16 FR SENTRANT SHEATH WAS THEN INSERTED ON THE LEFT TO MAINTAIN ACCESS FOR GATE CANNULATION FOR THE CONTRALATERAL LIMB. THE PHYSICIAN THEN REPORTEDLY PULLED THE SHEATH BACK AND LOST ACCESS IN THE TORTUOUS ILIAC ARTERY. THEY THEN ATTEMPTED TO INSERT THE SHEATH WITH A STIFF WIRE IN PLACE, BUT THE ILIAC ARTERY BECAME PERFORATED AND THE PATIENT BECAME UNSTABLE. THEY FINISHED PLACING THE IPSILATERAL SIDE OF THE MAIN BODY AND PLACED A RELIANT BALLOON ABOVE THE CELIAC ARTERY TO STABILIZE BLOOD PRESSURE. THE PHYSICIAN THEN OPTED TO PERFORM AN OPEN CONVERSION AND THE PHYSICIAN LEFT THE SHEATH IN THE ILIAC ARTERY UNTIL THE PROXIMAL REPAIR WAS COMPLETED. THE STENT GRAFT WAS PARTIALLY EXPLANTED AND AN AORTO-BIFEMORAL BYPASS GRAFT WAS SEWN IN AND TIED TO THE FEMORAL ARTERIES BILATERALLY. THIS REPORTEDLY RESOLVED THE EVENT AT THE TIME; HOWEVER, THE PATIENT EXPIRED LATER THAT EVENING FROM COMPARTMENT SYNDROME. THE PHYSICIAN STATED THAT THE CAUSE OF THE EVENT WAS DUE TO PATIENT ANATOMY; SPECIFICALLY, TORTUOS
Patient problems: Death; Perforation of Vessels
MAUDE report 6899927 ↗DeathApr 13, 2017Difficult to Insert; Difficult to Insert
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 5.1 CM IN DIAMETER ABDOMINAL AORTIC ANEURYSM AND A 2.5 CM IN DIAMETER RIGHT ILIAC ANEURYSM. VESSEL MORPHOLOGY WAS REPORTED AS SEVERE CALCIFICATION IN THE VESSELS. IT WAS REPORTED THAT THE RIGHT AND LEFT COMMON FEMORAL ARTERIES WERE EXPOSED AND CONTROLLED SECURED WITH A VESSEL LOOPS. USING AN 18GAUGE NEEDLE TO GAIN ACCESS INTO THE RIGHT COMMON FEMORAL VASCULAR ANATOMY. ANOTHER MANUFACTURER¿S 7FR SHEATH WAS PLACED AND A GLIDE WIRE WITH ANOTHER MANUFACTURER¿S CATHETER WERE ADVANCED TO THE SUPRARENAL AORTA. THE GLIDE WIRE WAS EXCHANGED FOR ANOTHER GUIDE WIRE. THE CATHETER AND SHEATH WERE REMOVED AND A SENTRANT 12FR SHEATH WAS ADVANCED TO THE EXTERNAL ARTERY. THE SENTRANT 12FR SHEATH WAS UNABLE TO BE ADVANCED INTO THE RIGHT COMMON ILIAC DUE TO THE CALCIUM. ANOTHER MANUFACTURER¿S DILATOR WAS USED TO DILATE THE COMMON AND EXTERNAL ILIAC ARTERIES. POST DILATATION THE PHYSICIAN ATTEMPTED TO ADVANCE THE SENTRANT 12FR SHEATH AGAIN WITHOUT SUCCESS. THE PHYSICIAN ELECTED TO ACCESS THE LEFT COMMON FEMORAL ARTERY. A 18GA NEEDLE WAS USED ALONG WITH SENTRANT 16FR SHEATH WAS USED TO GAIN ACCESS INTO THE
Patient problems: Death; Myocardial Infarction
MAUDE report 6491944 ↗
Other INTRODUCER, CATHETER devices
- VIZIGO D138502Biosense Webster Inc · INTRODUCER, CATHETER2 recalls4 deaths2,839 reports
- VIZIGO D138501Biosense Webster Inc · INTRODUCER, CATHETER2 recalls2 deaths2,005 reports
- Swartz™ 407451St. Jude Medical, Inc. · INTRODUCER, CATHETER5 deaths728 reports
- Edwards eSheath+ Introducer set 914ESPEdwards Lifesciences LLC · Introducer, Catheter22 deaths532 reports
- Fast-Cath™ 406849St. Jude Medical, Inc. · INTRODUCER, CATHETER420 reports
- VIZIGO D138503Biosense Webster Inc · INTRODUCER, CATHETER362 reports
- Agilis™ G408318St. Jude Medical, Inc. · INTRODUCER, CATHETER333 reports
- Agilis™ NxT Steerable Introducer Dual-Reach™ SI-1371-MSt. Jude Medical, Inc. · Introducer, catheter1 death301 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page